Clinical Trial Update: Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI). [Phase 3]

View source ↗

Summary

Phase 3 trial comparing prasugrel to high-dose clopidogrel in clopidogrel-resistant patients after PCI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Clopidogrel (Plavix) (clopidogrel)
• Prasugrel (Effient) (prasugrel)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease (CAD), Acute Coronary Syndrome (ACS) | Phase 3 | Status: COMPLETED